Grow Opportunity

News Business Marketing Medical
Cronos Group partners with Geocann to leverage VESIsorb® absorption tech

June 27, 2022  By Haley Nagasaki

(Globe Newswire) Toronto—Cronos Group Inc. launches the first of what they expect will be a range of products in partnership with Geocann, using the advanced absorption technology VESIsorb® delivery system. The characteristics of VESIsorb® include superior pharmacokinetic performance, faster absorption, and higher plasma concentration, thereby securing industry standard status.

Cannabinoids and terpenes are categorized along with other difficult-to-absorb ingredients, creating a demand in the cannabis industry for innovative technologies that increase bioavailability. At this time, Geocann is the exclusive supplier of the VESIsorb® absorption technology.

“We are committed to bringing breakthrough innovations to the market, providing consumers with differentiated and high-quality products. Working with Geocann’s technology enables us to expand our product offering to bring consumers a fast-acting cannabinoid product with a quicker onset than previously available, along with improved efficacy, helping enhance and differentiate effect and experience.” —Mike Gorenstein, Chairman, President and Chief Executive Officer, Cronos


Print this page


Stories continue below